Completed Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma NCT01208103 Conditions Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma, Stage III Ampulla of Vater Cancer AJCC v8, +7 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma NCT04111172 Conditions Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, +50 more Locations Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States View Trial Details
